menu search

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Initial Clinical Data Readout from Ongoing Phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Anticipated by End of 2023 Received $5 Million Research and Development Collaboration Milestone Payment from Merck Cash Runway into early 2025 SEATTLE, Aug. 11, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the […] The post Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update appeared first on ForexTV... Read More
Posted: Aug 11 2023, 20:01
Author Name: forextv
Views: 101993

Search within

Pages Search Results: